Testing effectiveness (Phase 2)Study completedNCT01607372
What this trial is testing
Investigate the Safety and Pharmacodynamics of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies
Who this might be right for
Asthma and Rhinitis
GlaxoSmithKline 18